-
-
-
-
-
-
-
Global Fibromyalgia Treatment Market Expected to Reach $4.6 billion by 2032
-
-
-
-
-
-
-
Pfizer (PFE) Announces FDA Approval of PADCEV with KEYTRUDA as the First and Only ADC Plus PD-1 to Treat Advanced Bladder Cancer
-
-
-
-
-
-
-
Pfizer (PFE) Guides FY24 Revenue of $58.5B-$61.5B, EPS of $2.05-$2.25
-
-
-
-
-
-
-
Pfizer to close Seagen deal this week, creates new cancer division
-
-
-
-
-
-
-
Apple, Nvidia and Pfizer fall premarket; Lululemon rises
-
-
-
-
-
-
-
Pfizer Invites Public to View and Listen to Webcast of October 31 Conference Call with Analysts
-
-
-
-
-
-
-
Pfizer Announces Executive Leadership to Advance Oncology Research and Development Strategy
-
916,711 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All